• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
DING Jinxi, LIU Yangyang, YAN Jianzhou. Negative effects of drug data protection system on drug availability — an empirical analysis of America lamotrigine case[J]. Journal of China Pharmaceutical University, 2015, 46(4): 493-498. DOI: 10.11665/j.issn.1000-5048.20150418
Citation: DING Jinxi, LIU Yangyang, YAN Jianzhou. Negative effects of drug data protection system on drug availability — an empirical analysis of America lamotrigine case[J]. Journal of China Pharmaceutical University, 2015, 46(4): 493-498. DOI: 10.11665/j.issn.1000-5048.20150418
shu

Negative effects of drug data protection system on drug availability — an empirical analysis of America lamotrigine case

More Information
    Graphical Abstract
    • Abstract
  • This paper explores the relevance between data protection system and drug availability through the American lamotrigine(lamictal® )case. Results indicated that drug data protection system delays the marketing of genetics, hinders the pricing regulation of innovative drugs timely and effectively, and affects drug availability severely. With reference to America, it is urgent to design the scope of data protection system reasonably, and set the first generic drug regime and other supporting measures so as to reduce the negative effects of drug data protection system and improve the health benefits of the public.
    • FullText(HTML)
    • References (20)
  • [1]
    Diao TX,Wu SH.The analysis of status and effect of the protection of drug test data[J].Bull Acad Mil Med Sci(军事医学科学院院刊),2007,31(2):160-162.
    [2]
    Wu SW,Han S,Cheng J,et al.Impact of medical data protection on drug expenditure and accessibility in China[J].Chin Pharm J(中国新药杂志),2012,21(20):2353-2355.
    [3]
    WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy-2000-2003[EB/OL].[2014-12-26] http://apps.who.int/medicinedocs/en/d/Jwhozip16e/1.html.
    [4]
    Gong SW.Study of management strategies of improving access to orphan drugs in China(促进我国罕见病患者药品可及性的管理策略研究)[D].Hubei:Huazhong University of Science and Technology,2008.
    [5]
    Jiang S.Policy to improve drug accessibility-compulsory license[J].Economic Tribune(经济论坛),2004,12:122-123.
    [6]
    Li HT.Analysis on the accessibility of drugs in China[J].Chin Health Serve Manage(中国卫生事业管理),2009,9:612-614.
    [7]
    Liu B,Wu RX,Ye L.Barrier of availability and accessibility to essential drugs[J].Chin Pharm(中国药房),2007,18(14):1041-1043.
    [8]
    Ding JX,Li XT,Zhao Y.The unify operation pattern of drug reimbursement list under the policy of new medical reform-based on the empirical analysis of the drug reimbursement list of new cooperation medical system[J].Chin Pharm Aff(中国药事),2011,25(10):962-968.
    [9]
    Li P.Study on strategies of improving access to essential medicines in rural of China(改善农村地区基本药物可获得性策略研究)[D].Hubei:Huazhong University of Science and Technology,2009.
    [10]
    Gong SW,Xu Y,Zhang L.study on evaluator indication system of drug accessibility[J].Chin Health Econ(中国卫生经济),2011,30(5):72-74.
    [11]
    Ding JX, Zhao M. The comparative study on supervision and incentive policies of sino-US during the innovative drug R&D[J].Chin J New Drugs(中国新药杂志),2009,18(5):387-396.
    [12]
    Yu XQ.Evolution of American generics[J].Chin J Pres Drug(中国处方药杂志),2008,78:47-50.
    [13]
    FDA Approved Drug Products.[EB/OL].[2014-02-13] http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails.
    [14]
    FDA Approved Drug Products.[EB/OL].[2014-02-13] http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=LAMOTRIGINE.
    [15]
    Yang L,Li Y.A study on data exclusivity protection for pharmaceutical products in the USA[J].Chin Pharm(中国药房),2007,18(10):730-734.
    [16]
    Zhang RW,Hu SL.A comparative study of international price for pharmaceuticals medicine price[J].Chin Health Econ(中国卫生经济),2001,20(2):26-28.
    [17]
    Lamictal Prices,Coupons and Patient Assistance Programs.[EB/OL].[2014-03-10] http://www.drugs.com/price-guide/lamictal.
    [18]
    US Bureau of Labor Statistics.[EB/OL].[2014-03-11] http://www.bls.gov.
    [19]
    Xu K.Distribution of health payment and catastrophic expenditure methodology.Geneva:department of health system financing[R].World health organization,2005.
    [20]
    Jesse C.Vivia.Generic-Substitution Laws[J].US Pharm,2008,33(6):30-34.
    • Related Articles

  • Related Articles

    [1]ZHOU Ying, ZHAO Xun, HU Nan, WANG Baocheng, YUAN Yaozuo. A method for rapid analysis of polysorbate 80 components[J]. Journal of China Pharmaceutical University, 2022, 53(2): 192-199. DOI: 10.11665/j.issn.1000-5048.20220209
    [2]MAO Dan. Patent analysis of pharmaceutical cocrystals technology in China[J]. Journal of China Pharmaceutical University, 2015, 46(4): 509-512. DOI: 10.11665/j.issn.1000-5048.20150421
    [3]ZHANG Dandan, TAN Ting, LIU Ehu, LI Ping. Applications of ionic liquids on extraction, separation and analysis of traditional Chinese medicines[J]. Journal of China Pharmaceutical University, 2013, 44(4): 380-384. DOI: 10.11665/j.issn.1000-5048.20130418
    [4]DI Bin, SU Mengxiang. Analysis methods and strategies in drug research[J]. Journal of China Pharmaceutical University, 2013, 44(1): 20-27. DOI: 10.11665/j.issn.1000-5048.20130103
    [5]HPLC Analysis of Metoprolol and Its Metabolites in the Perfusates[J]. Journal of China Pharmaceutical University, 1997, (6): 31-35.
    [6]NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35.
    [7]Studies on the Synthesis and Analysis of Impurities and Decomposition Product of Ondansetron Hydrochlorid[J]. Journal of China Pharmaceutical University, 1997, (4): 8-10.
    [8]The Preparation and Analysis of New Sweetener L-Asp-D-Ala-OiPr[J]. Journal of China Pharmaceutical University, 1997, (2): 114-115.
    [9]A Microprocessor-based Instrument for Flow Injection Analysis[J]. Journal of China Pharmaceutical University, 1991, (1): 8-11.
    [10]ANALYSIS OF TWENTY EIGHT ELEMENTS IN CHINESE DRUG MAIDONG[J]. Journal of China Pharmaceutical University, 1986, (4): 286-288.

Catalog

    Get Citation
    PDF
    XML
    Article views (1021) PDF downloads (2084) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：278787

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return